Neuland Laboratories Enterprise value
What is the Enterprise value of Neuland Laboratories?
The Enterprise value of Neuland Laboratories Limited is $318.08M
What is the definition of Enterprise value?
Enterprise value is a measure of a company’s total market value. It is calculated as market capitalization with debt, minority interest, and preferred shares minus total cash and cash equivalents.
ttm (trailing twelve months)
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Enterprise value of companies in the Health Care sector on BSE compared to Neuland Laboratories
What does Neuland Laboratories do?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Companies with enterprise value similar to Neuland Laboratories
- Madras Fertilizers has Enterprise value of $317.43M
- Voltamp Transformers has Enterprise value of $317.51M
- Zuari Agro Chemicals has Enterprise value of $317.66M
- Budding Times has Enterprise value of $317.73M
- Schroder UK Mid Cap Fund Plc has Enterprise value of $317.77M
- Chiho Environmental has Enterprise value of $317.93M
- Neuland Laboratories has Enterprise value of $318.08M
- Newton Resources Ltd has Enterprise value of $318.13M
- Akebia Therapeutics has Enterprise value of $318.16M
- TMAC Resources has Enterprise value of $318.89M
- accesso Technology Plc has Enterprise value of $319.15M
- Noranda Income Fund has Enterprise value of $319.19M
- Discovery Metals has Enterprise value of $319.21M